1. Market Research
  2. > Diagnostics

Diagnosis Equipment Market: Latest Industry Trends and Statistics

  • Currently 4/5 Stars.
  • 1
  • 2
  • 3
  • 4
  • 5
12 votes

Topics under Diagnostics

Global Diagnostics Industry

The diagnostics industry involves testing patients to detect disease. Diagnosis can be used in the case of patients already presenting symptoms of disease, to screen asymptomatic patients as a matter of routine, and to allow ongoing testing in patients with disease to establish prognosis or check progress of therapy. The section is part of the wider medical devices industry.

The market can be broadly divided into:

  1. In vitro diagnostics (IVD), which refers to testing samples of blood, tissue, for example electrocardiography; and
  2. Medical imaging, such as x-rays, computerized axial tomography (CAT), mammograms and magnetic resonance imaging (MRI).

Leading Market Segment

The IVD market, estimated at $44 billion in 2010, is predicted to reach $52 billion by 2013 with a compound annual grown rate of approximately 5%, according to research from RNCOS. A particularly profitable growth sector within IVD, molecular diagnostics is predicted to reach $15 billion by 2014 at a compound annual growth rate of just under 20% reports Renub Research. Infectious diseases account for more than a fifth of this segment, followed by oncology testing. By 2014 blood testing and genetic screening together will account for over a quarter of the market, with the US representing $6 billion of the molecular diagnostics market by that time.

Blood grouping reagent Export

Regional Market Share

The In Vitro Diagnostic market is dominated by the US and the EU, which combined comprise about three quarters of the global market. This is because developed countries are witnessing a proliferation of diet and lifestyle related diseases such as cancer, diabetes and cardiovascular disease, whereas developing countries are more concerned with the diagnosis of infection and infectious disease.

In the lead, the IVD market in the US is forecast to grow 5.4% annually, reaching $23 billion in 2013. According to Global Industry Analysts, the US molecular diagnostics market will be over $6.35 billion by 2015.

Following behind, the EU represents the second-largest regional market, with its infectious-disease testing market estimated to reach $1.02 billion in 2012. There is strong growth in oncology testing and pharmacogenomics, which are predicted to show a compound annual growth rate of 10.71% and 11.05%, respectively, between 2011 and 2015.

Top 3 Diagnostics Players

Roche is the market leader in IVD, holding approximately 20% of total market share, followed by Abbott and Siemens, each holding more than 10%.

Roche’s 20% market share represents yearly sales of $44 billion, with key products such as CoaguChek and Accu-Chek fueling the company’s growth. Roche saw 20% growth in Asia-Pacific alone and a 5% rise in the US. Acquisitions, such as in diabetes care (Medingo Ltd) and tissue diagnostics (Biolmagene Inc), should see continued market growth for Roche going forward.

In business for over 120 years, Abbott's sales in 2010 reached over $35 billion, and it invested $3.7 billion in R&D. Its main area of expertise in diagnostics is immunodiagnostics. Abbott's immunoassay diagnostic systems, AxSYM, is used to test for cardiovascular disease, cancer, infectious diseases and thyroid conditions.

Read more »

24/7 Customer Support

Talk to Sam

+1 718 473 0872

1-10 of about 1 900 reports

Global Diagnostics Industry

  • February 2016
    5 pages
  • Diagnostics  


  • World  

View report >

Diagnostics Industry in the US and Ukraine

  • March 2016
    30 pages
  • Needle  

    Medical Supply  

  • United States  


View report >

In Vitro Diagnostic Industry in Europe

  • April 2016
    5 pages
  • Medical Devices  

    Medical Devices  

  • Europe  


View report >

HIV Diagnostic Industry in Japan

  • August 2015
    10 pages
  • HIV Diagnostic  

  • Japan  

View report >

The future of the Diagnostics Industry in France

  • January 2015
    8 pages
  • Blood Disease  


  • France  

View report >

In Vitro Diagnostic Reagent Industry in the US and Italy

  • January 2014
    7 pages
  • Vitamin  

    In Vitro Diagno  

  • Italy  

    United States  

View report >

Diagnostic Industry in the UK Forecast

  • March 2016
    13 pages
  • Diagnostic  

  • United Kingdom  


View report >

In Vitro Diagnostic Reagent Industry in Canada

  • January 2015
    9 pages
  • In Vitro Diagno  

  • Canada  

View report >

Diagnostic Test Industry in Brazil and the US

  • July 2015
    11 pages
  • Diagnostic Test  


  • Brazil  

    United States  

View report >

About 12 000 reports

Purchase Reports From Reputable Market Research Publishers
(From $ 99 - $ 28 500)

2016-2020 Analysis of the Global Tumor Marker Testing Market: Emerging Opportunities and Growth Strategies for Instrument and Reagent Suppliers

2016-2020 Analysis of the Global Tumor Marker Testing Market: Emerging Opportunities and Growth Strategies for Instrument and Reagent Suppliers

  • $ 28 500
  • Industry report
  • May 2016
  • by Venture Planning Group

Highlights - Identifies and evaluates major business opportunities emerging in the tumor marker market during the next ten years- Examines trends in the U.S., Europe and Japan- Reviews current and emerging ...

Microbiology 2016-2020: Molecular Diagnostics, Microbia ...

May 2016 $ 22 400

2016-2020 New Frontiers In The Global Automated Microb ...

March 2016 $ 22 400

2016-2020 World Automated Microbiology Market: Molecula ...

March 2016 $ 22 400

2016-2020 World Microbiology Analyzers And Consumables ...

March 2016 $ 22 400

Competing In The 2016-2020 Global Clinical Chemistry An ...

May 2016 $ 21 800

Cancer Diagnostics 2016-2020: Emerging Tumor Markers, O ...

May 2016 $ 21 100

Competing In The 2016-2020 Global Infectious Disease Te ...

May 2016 $ 21 100

Competing In The 2016-2020 Global Hematology And Flow C ...

May 2016 $ 21 100

Competing In The 2016-2020 Global Coagulation Testing M ...

May 2016 $ 21 100

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.